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We discuss pooling methods of mutation detection for identifying rare mutations. We provide mathematical formulae
for obtaining the optimal pool size as a function of the mutation frequency in the study population and the specificity
of the test. The optimal pool size depends strongly on the specificity of the test. With a test that has 99% specificity,
pooling can reduce the number of tests that need to be performed by 80%, whereas, with a test with 95% specificity,
pooling reduces the number of samples that must be tested by only 50%. We used the software PHRED to call
mutations after sequencing of pooled samples with known STK11 mutations. We found that, when the area under
the curve for the less prominent peak was used to call mutations, we were able to pool pairs of samples and
correctly identify mutations. Pooling of three samples did not lead to an adequately specific test for the basic
automated allele-calling procedures that we used. We discuss methods by which the specificity may be improved
to permit pooling of three or more samples when testing for mutations by sequencing.
Pooling strategies have been advocated for genetic-link-
age identification (Churchill et al. 1993; Sheffield et al.
1995), detection of clones for physical-mapping studies
(Barillot et al. 1991; Bruno et al. 1995), and association
studies (Daniels et al. 1998; Shaw et al. 1998) but have
not been widely employed for mutation detection in
individual patients. Nevertheless, the cost for mutation
detection for genes such as BRCA1 and BRCA2 and the
DNA mismatch–repair genes, hMLH1 and hMSH2, can
be prohibitive. A typical mutation-detection protocol
requires that for each individual to be tested, each
exon—or, possibly, a few closely located exons—is PCR
amplified and then assayed. BRCA1 mutations are
among the more common major genes causing familial
illness. Nevertheless, population estimates for the prev-
alence of BRCA1 or BRCA2 mutations range from
!0.3% among non-Jewish whites (Claus et al. 1991), to
∼2% for Ashkenazim (Hartge et al. 1999). Furthermore,
mutations in BRCA1 or BRCA2 (and in most other can-
cer-predisposing loci) are scattered throughout the cod-
ing region for most populations, so that the probability
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that any particular amplified segment contains a mu-
tation is much lower than the probability for the entire
gene. Except in some special populations, common mu-
tations of cancer-predisposing genes do not exist. The
rarity of mutations within exons of these commonly
studied genes further reinforces the need to develop
DNA-pooling strategies to detect mutations more
efficiently.
A major issue in single-nucleotide-polymorphism
studies is identification of polymorphisms through re-
sequencing of already cloned genes (Mohrenweiser and
Jones 1998). For these studies, the targeted gene fre-
quency is generally on the order of >10% per exon, and
pooling is not likely to be effective during the current
period in which common alleles are sought. However, if
future studies seek to identify unusual polymorphisms
(Taillon-Miller et al. 1999), then resequencing efforts
including larger numbers of subjects may benefit from
some of the design issues we describe here.
A limiting factor in the use of pooling strategies is the
sensitivity of the assay. By sensitivity, we mean the prob-
ability to detect a mutation given that the mutation is
present in some member of the DNA pool. Data con-
cerning the sensitivity of mutation detection methods in
pooled samples is not available for the frequently used
methods such as direct sequencing or single stranded
conformational polymorphism analysis. However, for
detection of mutations using multiplex single nucleotide
primer extension, pooling of 10 or 20 samples led to an
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Table 1
Mutation Frequency versus the Optimal Pooling Strategy and Average Sample Size Required
with Pooling, as a Percentage of the Size Needed without Pooling
Mutation
Frequency
Per Exon (p)
Optimal
Pool Size
(p)
Average Optimal
Sample Size
with Pooling (y/n)
Optimal Pool Size
with 5% False-
Positive Results
Average Sample Size
with Pooling with 5%
False-Positive Results
.4 1 No improvement 1 No improvement
.2 1 No improvement 1 No improvement
.1 2 88.0% 2 96.1%
.05 2 69.5% 2 78.5%
.01 4 40.8% 3 56.8%
.005 5 32.4% 4 52.5%
.001 7 18.9% 4 46.5%
.0005 10 15.0% 4 45.8%
.0001 17 8.8% 4 45.2%
estimated 100% sensitivity, whereas, for pools of 30
samples, the sensitivity dropped to 80% (Krook et al.
1992). Coolbaugh-Murphy et al. (1999) found that for
detecting microsatellite genotypes that pools of <5 ge-
nome equivalents provided a test with adequate sensi-
tivity. In this study, samples were pooled prior to the
PCR amplification. For direct sequencing, data are not
available concerning the sensitivity of pooled samples
for mutation detection, and we provide results from in-
itial studies on this issue. Finally, the mismatch ampli-
fication mutation assay is sensitive for detecting specific
mutations in large pools (on the order of 1 mutation in
105 samples) so that multistage pooling may be feasible
with this assay, but the sensitivity and specificity were
not clearly presented (Chen and Zarbl 1997). In this
letter, we are assuming that the maximal pool size to
ensure 100% sensitivity for the assay is small (!10) so
that multistage pooling is not appropriate. The statistical
approach is applicable for any type of assay with rela-
tively small pools but we have specifically studied issues
related to sequence analysis.
Suppose that samples are obtained from n subjects
and that one wants to identify the optimal number of
samples to pool, r. Assume that the probability of de-
tecting a mutation in a pool of size r is given by g. Let
the probability of a mutation in a single exon (or other
unit being studied) be p. The number of mutation-de-
tection runs that must be completed without pooling is
just n. With single-stage pooling, the expected number
of runs to complete the mutation detection, y, is given
by
n
y = 1 ngr .
r
The sample is first organized into n/r pools. We expect
that ng runs will show mutations and that, for each of
these pools, r samples will have to be resequenced to
identify the sample(s) that contain the mutation(s). Any
given pool that is found to have a mutation could con-
tain one or more mutations, so every sample in the pool
needs to be sequenced. Now, , becauserg = 1 2 (1 2 p)
the probability of detecting at least one mutation in a
pool is 1 minus the probability of detecting no mutations
in the r independent pools of the sample. Thus, we need
only minimize the equation
1 r( )y = n 1 r 1 2 1 2 p[ ]{ }r
over r to obtain an optimal pool size. Differentiating y
with respect to r, the resulting equation to solve is:
1 r( )0 = 1 2 2 1 2 p [1 1 r log (1 2 p)]e2r
This formula does not have a simple solution. However,
some values minimizing this expression have been pro-
vided in table 1, along with the required expected num-
ber of samples that will have to be performed. Evalua-
tion of the second derivative confirms that, for small
values of p, the function is minimized (results not
shown). When studying sex-linked traits, p can be taken
to be the gene frequency of the disease allele, while for
autosomal traits, if p is the allele frequency, then p =
.22p(1 2 p) 1 2p
False-positive findings increase the number of samples
that will have to be assayed. If we let b be the probability
of a false-positive result (and be the specificity),1 2 b
then the number of samples that need to be assayed in
the presence of any false-positive findings becomes
1 r( ) ( )y = n 1 r 1 2 1 2 b 1 2 p (1)[ ]{ }r
The righthand columns of table 1 provide optimal pool
sizes and sample size reductions under the assumption
of a 5% false-positive rate for various gene frequencies.
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Figure 1 Proportion of tests required when pooled samples are
used, with varying specificity of the test.
Figure 2 Distribution of area under second base for 6,041 nu-
cleotides compared with nine sets of pooled samples. Results from
different mutations are arranged in pairs, according to whether the
pool size included two or three samples.
We have also plotted, in figure 1, the reduction in the
number of tests that can be accomplished versus the
mutation frequency for a range of specificities of the test.
The frequency of false-positive results is the critical fac-
tor in determining the optimal pool size for any pooling
strategy.
Currently available technology for sequencing restricts
the pool size that can be reliably used for mutation de-
tection. To evaluate the sensitivity of sequencing meth-
ods, we created pools of samples of DNA from nine
patients previously identified to have a mutations or
polymorphisms in LKB1 and who had Peutz-Jeghers syn-
drome (PJS). Two patients with PJS had microdeletions,
and the remaining patients had missense mutations or
polymorphisms; two subjects had two polymorphisms
each, so that we studied 11 mutations in all. The pool
size that we assayed included two or three subjects in
each pool. PCR products were generated for specific ex-
ons known to have a mutation or polymorphism, and,
in the pooling experiments, equal quantities of PCR
product were pooled with the PCR product of the known
mutation carrier or individual with a polymorphism.
The samples were subjected to nucleotide-sequence anal-
ysis using an Applied Biosystems model 377 sequencer.
We used the BigDye Terminator kit to minimize errors
in base calling. The microdeletions were easily identifi-
able in pools of size two or three, and results are not
further described.
To quantitate results, we used PHRED (Ewing et al.
1998). We evaluated the area under the base having the
second largest area (corresponding to the mutation or
polymorphism). As a referent, we quantitated the second
largest areas from 6,041 bases not containing mutations
derived from the original sequence analyses on the un-
pooled samples that identified the nine mutations. For
all analyses, we deleted the first 20 bases at the beginning
and end of each run, because of the increased error rates
in base calling in these regions (Ewing and Green 1998).
The results are shown in figure 2. Of the 6,041 referent
bases, 89 had nonzero values. Compared with the pools
of size two, none of the referent bases exceeded the area
under the second base for the pooled sample, but, for
pools of size three, 15 referent bases exceeded the area
under the second base of the pooled sample. Since the
largest referent bases were randomly distributed among
exons, the specificity of the test (which depends upon
the chance that an entire exon has a base exceeding the
threshold) would have to be set at an excessively low
level. Thus, pools of size three are not practical with this
current technology in this study, while pools of size two
were practical in this study.
The sequencing software that we have used in this
preliminary study is not optimized for mutation detec-
tion in pooled samples, and so it is not surprising that
the accuracy of the assay in pools of size three is not
acceptable. Further development of sequencing software
should allow signal identification for larger pools of
samples, but even with pooling of two individuals per
sample a substantial reduction in the number of tests
can be accomplished. For example, application of for-
mula 1 indicates that—for allele frequencies of .001,
.0005, and .0001—only 52%, 50.4%, and 50% of the
number of tests without pooling, respectively, need to
be performed if the specificity of the test is 100%.
A larger set of experiments needs to be performed.
Perusal of the larger second-base areas shows that the
pattern of the second peak has a different appearance
when it is likely to be due to background, as opposed
to when it reflects a mutation in a pooled sample. In the
former case, the background peaks are asymmetrical and
reflect shoulders from a neighboring base, whereas, in
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the latter case, the peak is symmetrical and may not be
related to neighboring bases. We used the area under
the second base to detect mutations; however, it may be
possible, with a large set of sequencing runs, to develop
algorithms on the basis of the area under the first base.
The area under the first base is highly variable among
locations and depends on the neighboring bases. How-
ever, across runs, the area under the first base shows
little variation. Thus, if a substantial pool of sequences
of the same exon have been completed, it should be
possible to develop algorithms directed at detecting a
significantly decreased signal in the first base which re-
sults when a second base is present at the same location.
This analysis neglects further approaches that might
be taken to optimize mutation detection. We assume that
only four colors are available for colorimetry, so that
samples must be identically labeled. If individual samples
could be identified within a pool by using different flu-
orescein dyes, further increases in efficiency would be
possible. In this article, we have assumed negligible false-
negative findings. For clinical studies, false-negative find-
ings are not acceptable, and, in general, maintaining a
high sensitivity may impose a bound on the number of
samples that can be pooled. For population-based stud-
ies in which false-positive and false-negative findings
may be acceptable, further studies should be performed
to identify optimal pooling strategies, allowing for the
cost to the study associated with false-positive or false-
negative test results. However, our results indicate that,
for assays such as sequence analysis—even when only a
few samples can be pooled to yield a sensitive test—a
substantial reduction in the number of tests and, there-
fore, a reduction in cost should be possible. Equation
(1) indicates the reduction in the number of tests asso-
ciated with pooling for any pool size. The efficacy of
pooling is strongly related to the specificity of the test.
However, even with a 5% false-positive rate, only about
half as many tests would need to be performed if a pool-
ing strategy is adopted.
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